Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication December 12, 2013
- Accepted for publication February 24, 2014
- Published online April 1, 2014.
Article Versions
- previous version (March 10, 2014 - 07:07).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Author Information
- 1Radiology/Nuclear Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and
- 2Medicine/Medical Oncology and Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
- For correspondence or reprints contact: David A. Mankoff, 116 Donner Building, Hospital of the University of Pennsylvania, 3400 Spruce St., Philadelphia, PA 19104-4283. E-mail: david.mankoff{at}uphs.upenn.edu
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- SNMMI Clinical Trials Network Research Series for Technologists: Clinical Research Primer--Use of Imaging Agents in Therapeutic Drug Development and Approval
- Building the Bridge: Molecular Imaging Biomarkers for 21st Century Cancer Therapies
- The Future of Nuclear Medicine, Molecular Imaging, and Theranostics
- Imaging Diagnostic and Therapeutic Targets: Human Epidermal Growth Factor Receptor 2
- Molecular Imaging of Biomarkers in Breast Cancer
- Quantitative Imaging in Cancer Clinical Trials
- Predictive Value of Positron Emission Tomography/Computed Tomography to Assess Early Treatment Response to Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade Without Chemotherapy for HER2-Positive Metastatic Breast Cancer: Are We Ready to Embrace This "Early Metabolic Look" Strategy?
- The Value of Establishing the Quantitative Accuracy of PET/CT Imaging
- Measuring Tumor Metabolism by 18F-FDG PET Predicts Outcome in a Multicenter Study: A Step Off in the Right Direction